Full name
"LABORATORIUM DIAGNOSTYKI MOLEKULARNEJ" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
86.90.E - Other human health activities notelsewhere classified
68.20.Z - Rental and operating of own or leased real estate
72.11.Z - Research and experimental development on biotechnology
72.19.Z - Other research and experimental development on natural sciences and engineering
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | 304,7 | 76,4 | 86,7 | 13,5 |
EBITDA | 326,6 | 125,2 | 129,4 | 3,3 |
Short time liabilities | 35,8 | 36,3 | 38,5 | 6 |
Equity capital | 347,4 | 368,3 | 407,8 | 10,7 |
Operating profit (EBIT) | 306 | 77,6 | 86,9 | 11,9 |
Assets | 383,4 | 404,6 | 446,3 | 10,3 |
Net profit (loss) | 274,8 | 68,3 | 77,8 | 13,9 |
Cash | 257,8 | 339,9 | 397,4 | 16,9 |
Net income from sale | 716 | 451 | 530,3 | 17,6 |
Liabilities and provisions for liabilities | 36,1 | 36,3 | 38,5 | 6 |
Working assets | 287,4 | 356,2 | 440,3 | 23,6 |
Depreciation | 20,6 | 47,6 | 42,5 | -10,8 |
% | % | % | p.p. | |
Profitability of capital | 79,1 | 18,5 | 19,1 | 0,6 |
Equity capital to total assets | 90,6 | 91 | 91,4 | 0,4 |
Gross profit margin | 42,6 | 16,9 | 16,3 | -0,6 |
EBITDA Margin | 45,6 | 27,8 | 24,4 | -3,4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 18 | 29 | 26 | -3 |
Current financial liquidity indicator | 7.969870567321777 | 9.808452606201172 | 11.439238548278809 | 1,6 |
Net dept to EBITDA | -0.789405882358551 | -2.7136666774749756 | -3.0714528560638428 | -0,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane